8099 related articles for article (PubMed ID: 206566)
1. Co-cultivation of tumorigenic mouse melanoma cells with cells of a non-tumorigenic subclone inhibits plasminogen activator expression by the melanoma cells.
Kyner D; Christman J; Acs G; Silagi S; Newcomb EW; Silverstein SC
J Cell Physiol; 1978 May; 95(2):159-67. PubMed ID: 206566
[TBL] [Abstract][Full Text] [Related]
2. Malignant mouse melanoma cells do not form tumors when mixed with cells of a non-malignant subclone: relationships between plasminogen activator expression by the tumor cells and the host's immune response.
Newcomb EW; Silverstein SC; Silagi S
J Cell Physiol; 1978 May; 95(2):169-77. PubMed ID: 306389
[TBL] [Abstract][Full Text] [Related]
3. Relationship between rejection of several syngeneic tumors and retrovirus production by 5-bromodeoxyuridine-grown melanoma cells: lack of protection in natural killer-deficient beige mice.
Silagi S; Calvelli TA
Cancer Res; 1982 Jul; 42(7):2562-6. PubMed ID: 7083149
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of plasminogen activator from the transformed phenotype in a 5-bromodeoxyuridine dependent mutant of Syrian hamster melanoma cells.
Rosenthal SL; Zucker D; Davidson RL
J Cell Physiol; 1978 Jun; 95(3):275-85. PubMed ID: 649664
[TBL] [Abstract][Full Text] [Related]
5. Correlated suppression by 5-bromodeoxyuridine of tumorigenicity and plasminogen activator in mouse melanoma cells.
Christman JK; Silagi S; Newcomb EW; Silverstein SC; Acs G
Proc Natl Acad Sci U S A; 1975 Jan; 72(1):47-50. PubMed ID: 123336
[TBL] [Abstract][Full Text] [Related]
6. Reversible suppression of malignancy and differentiation of melanoma cells.
Silagi S
Am J Pathol; 1977 Dec; 89(3):671-84. PubMed ID: 596422
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of matrix metalloproteinases and serine proteases activities in three B16 melanoma cell lines with distinct tumorigenic potential.
Baramova EN; Coucke P; Leprince P; De Pauw-Gillet MC; Bassleer R; Foidart JM
Anticancer Res; 1994; 14(3A):841-6. PubMed ID: 8074484
[TBL] [Abstract][Full Text] [Related]
8. Secretion of proteinase inhibitors by tumorigenic and nontumorigenic guinea pig and Syrian hamster fibroblasts: evidence for autocrine regulation of local proteolysis.
McCabe RP; Evans CH
Cancer Res; 1984 Apr; 44(4):1392-7. PubMed ID: 6423273
[TBL] [Abstract][Full Text] [Related]
9. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.
Wang BS; McLoughlin GA; Richie JP; Mannick JA
Cancer Res; 1980 Feb; 40(2):288-92. PubMed ID: 7356511
[TBL] [Abstract][Full Text] [Related]
10. Steroid stimulation of plasminogen activator production in a human breast cancer cell line (MCF-7).
Butler WB; Kirkland WL; Gargala TL; Goran N; Kelsey WH; Berlinski PJ
Cancer Res; 1983 Apr; 43(4):1637-41. PubMed ID: 6682006
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte subpopulations elicited by a nontumorigenic variant of B16 melanoma: their role in direct rejection of the melanoma and in prevention of tumorigenesis in Winn assays.
Calvelli TA; Freedman VH; Silverstein SC; Silagi S
J Exp Med; 1982 Dec; 156(6):1723-38. PubMed ID: 6983560
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activators in nude mice xenotransplanted with human tumorigenic cells.
Colombi M; Bellotti D; De Petro G; Barlati S
Invasion Metastasis; 1995; 15(1-2):22-33. PubMed ID: 7672929
[TBL] [Abstract][Full Text] [Related]
13. Production of plasminogen activator in a melanoma cell line.
Matsuo O; Sakai T; Matsuo C; Nishida Y; Akazawa K; Mihara H
Acta Physiol Lat Am; 1983; 33(4):305-13. PubMed ID: 6377823
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activators and their inhibitors in the neuromuscular system: I. Developmental regulation of plasminogen activator isoforms during in vitro myogenesis in two cell lines.
Festoff BW; Rao JS; Maben C; Hantaï D
J Cell Physiol; 1990 Aug; 144(2):262-71. PubMed ID: 2199466
[TBL] [Abstract][Full Text] [Related]
15. Intracellular plasminogen activator activity in growing and quiescent cells.
Loskutoff DJ; Paul D
J Cell Physiol; 1978 Oct; 97(1):9-16. PubMed ID: 213444
[No Abstract] [Full Text] [Related]
16. Correlation between plasminogen activator activity of immunizing tumor cells and complement-mediated cytotoxic antibodies secreted by cloned hybrid cells.
Hakim AA
Cancer Biochem Biophys; 1980; 5(1):63-74. PubMed ID: 7194136
[TBL] [Abstract][Full Text] [Related]
17. Mitogenic activity and plasminogen activator in harvest fluid concentrates from mammary cells in culture.
Howard EF; Cheng CY; Howard JS
Cancer Res; 1980 Dec; 40(12):4385-9. PubMed ID: 7192175
[TBL] [Abstract][Full Text] [Related]
18. Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice.
de Vries TJ; Kitson JL; Silvers WK; Mintz B
Cancer Res; 1995 Oct; 55(20):4681-7. PubMed ID: 7553649
[TBL] [Abstract][Full Text] [Related]
19. Glycosaminoglycans synthesized by tumorigenic and nontumorigenic mouse melanoma cells in culture.
Heaney-Kieras J; Kieras FJ
J Natl Cancer Inst; 1980 Dec; 65(6):1345-50. PubMed ID: 6933279
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and secretion of plasminogen activators and plasminogen activator inhibitors in cell lines of different groups of human lung tumors.
Heidtmann HH; Hofmann M; Jacob E; Erbil C; Havemann K; Schwartz-Albiez R
Cancer Res; 1989 Dec; 49(24 Pt 1):6960-5. PubMed ID: 2555056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
